Walleye Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.82M Buy
182,400
+1,600
+0.9% +$46.9K 0.01% 1163
2025
Q4
$5.24M Buy
180,800
+39,500
+28% +$1.19M 0.01% 1271
2025
Q3
$3.92M Buy
141,300
+20,200
+17% +$510K 0.01% 1384
2025
Q2
$2.95M Sell
121,100
-1,900
-2% -$41.6K 0.01% 1503
2025
Q1
$2.55M Sell
123,000
-4,900
-4% -$123K 0.01% 1478
2024
Q4
$3.01M Buy
127,900
+7,900
+7% +$194K 0.01% 1458
2024
Q3
$3.07M Buy
120,000
+19,400
+19% +$494K 0.01% 1416
2024
Q2
$2.36M Sell
100,600
-100
-0.1% -$2.52K 0.01% 1505
2024
Q1
$2.9M Buy
100,700
+45,300
+82% +$1.36M 0.01% 1493
2023
Q4
$1.82M Buy
55,400
+19,700
+55% +$536K ﹤0.01% 2002
2023
Q3
$995K Sell
35,700
-600
-2% -$19.6K ﹤0.01% 2365
2023
Q2
$1.24M Buy
36,300
+7,300
+25% +$229K ﹤0.01% 1997
2023
Q1
$872K Sell
29,000
-52,600
-64% -$1.63M ﹤0.01% 2319
2022
Q4
$2.3M Sell
81,600
-22,300
-21% -$708K 0.01% 1574
2022
Q3
$3.42M Sell
103,900
-46,500
-31% -$1.71M 0.01% 1297
2022
Q2
$4.74M Buy
150,400
+9,800
+7% +$343K 0.02% 1073
2022
Q1
$6.46M Buy
+140,600
New +$6.7M 0.02% 854
2021
Q4
Sell
-18,700
Closed -$1.4M 5316
2021
Q3
$1.4M Buy
18,700
+1,400
+8% +$117K 0.01% 1893
2021
Q2
$1.6M Buy
17,300
+11,400
+193% +$969K 0.01% 1690
2021
Q1
$524K Buy
+5,900
New +$585K ﹤0.01% 2601

Other funds holding ARKG

Walleye Trading's ARKG Position: Q1 2026 in Review

Walleye Trading reduced its ARK Genomic Revolution ETF (ARKG) stake by 20% in Q1 2026, selling an estimated $523K and leaving 70,990 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1750.

Walleye Trading first reported a position in ARKG in Q3 2021 and has held it in 8 quarters since. The position peaked at $4M in Q4 2023. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Walleye Trading held 70,990 shares of ARK Genomic Revolution ETF worth $1.88M as of Q1 2026.
  • Walleye Trading sold 17,849 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $523K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #1750 holding.
  • Walleye Trading first reported a position in ARK Genomic Revolution ETF in Q3 2021 and has held it in 8 quarters since.
  • Walleye Trading's ARK Genomic Revolution ETF position peaked at $4M in Q4 2023.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.